TNF and dry eye syndrome: In a murine model of dry eye, these nanocomplexes significantly reduced inflammatory markers, including TNF-α, ICAM-1, VCAM-1, MMP-2, MMP-9, IL-17, IL-1β, and IL-6, thereby underscoring their therapeutic utility in DED [115].